Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Dimerix Limited (AU:DXB)
ASX:DXB
Dimerix Limited (DXB) Stock Price & Analysis
1 Followers
DXB Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.07 - AU$0.18
Previous CloseAU$0.08
Volume81.30K
Average Volume (3M)525.34K
Market Cap
AU$32.09M
Enterprise ValueAU$22.53M
Total Cash (Recent Filing)AU$9.63M
Total Debt (Recent Filing)AU$73.10K
Price to Earnings (P/E)-1.8
Beta0.41
Next Earnings
Aug 30, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding322,748,666
10 Day Avg. Volume548,720
30 Day Avg. Volume525,337
Standard Deviation3.39
R-Squared0.00644
Alpha0.51
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
DXB FAQ
What was Dimerix Limited’s price range in the past 12 months?
Dimerix Limited lowest stock price was AU$0.07 and its highest was AU$0.18 in the past 12 months.
What is Dimerix Limited’s market cap?
Currently, no data Available
When is Dimerix Limited’s upcoming earnings report date?
Dimerix Limited’s upcoming earnings report date is Aug 30, 2023 which is in 91 days.
How were Dimerix Limited’s earnings last quarter?
Dimerix Limited released its earnings results on Feb 26, 2023. The company reported -AU$0.029 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.029.
Is Dimerix Limited overvalued?
According to Wall Street analysts Dimerix Limited’s price is currently Overvalued.
Does Dimerix Limited pay dividends?
Dimerix Limited does not currently pay dividends.
What is Dimerix Limited’s EPS estimate?
Dimerix Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dimerix Limited have?
Dimerix Limited has 427,831,540 shares outstanding.
What happened to Dimerix Limited’s price movement after its last earnings report?
Dimerix Limited reported an EPS of -AU$0.029 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -12.5%.
Which hedge fund is a major shareholder of Dimerix Limited?
Currently, no hedge funds are holding shares in AU:DXB
---
Dimerix Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.18%
12-Months-Change
Fundamentals
Return on Equity
-117.16%
Trailing 12-Months
Asset Growth
-69.07%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Dimerix Limited
Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.
---
---